01. What Are Completed Clinical Trials?
What Makes a Clinical Trial Complete?
A completed mesothelioma clinical trial is no longer testing treatments on patients.
There are four phases that mesothelioma clinical trials go through. In Phase I new mesothelioma drugs or treatments are tested in a small group of participants. Phase II evaluates the same drug or treatment therapy in a larger group. Phase III involves an even larger population of participants and Phase IV takes place post-licensing and marketing of a new drug or treatment.
02. List of Completed Clinical Trials
Completed Clinical Trials for Mesothelioma
The clinical trials listed below have completed. Please click on a link to learn more about the study and the study results.
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Conditions: Mesothelioma
Last Updated: August 16, 2021
Status: Completed
Locations: Scottsdale, AZ. San Francisco, CA. Hartford, CT. New Britain, CT. Lewes, DE. Newark, DE. Boise, ID. Bloomington, IL. Bloomington, IL. Canton, IL. Carthage, IL. Chicago, IL. Eureka, IL. Eureka, IL. Galesburg, IL. Havana, IL. Kewanee, IL. La Grange, IL. Macomb, IL. Monmouth, IL. Monmouth, IL. Normal, IL. Normal, IL. Normal, IL. Ottawa, IL. Ottawa, IL. Pekin, IL. Pekin, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peru, IL. Peru, IL. Princeton, IL. Spring Valley, IL. Elkhart, IN. Elkhart, IN. Elkhart, IN. Kokomo, IN. La Porte, IN. Mishawaka, IN. Mishawaka, IN. Plymouth, IN. South Bend, IN. South Bend, IN. Westville, IN. Sioux City, IA. Sioux City, IA. Sioux City, IA. Chanute, KS. Dodge City, KS. El Dorado, KS. Fort Scott, KS. Independence, KS. Kingman, KS. Lawrence, KS. Liberal, KS. McPherson, KS. Newton, KS. Parsons, KS. Pratt, KS. Salina, KS. Wellington, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Winfield, KS. Baton Rouge, LA. Covington, LA. New Orleans, LA. New Orleans, LA. New Orleans, LA. Baltimore, MD. Baltimore, MD. Elkton, MD. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Flint, MI. Flint, MI. Grand Blanc, MI. Grosse Pointe Woods, MI. Jackson, MI. Lansing, MI. Livonia, MI. Pontiac, MI. Port Huron, MI. Saginaw, MI. Saint Joseph, MI. Saint Joseph, MI. Warren, MI. Brainerd, MN. Duluth, MN. Duluth, MN. Duluth, MN. Minneapolis, MN. Rochester, MN. Las Vegas, NV. Las Vegas, NV. Voorhees, NJ. East Syracuse, NY. Syracuse, NY. Durham, NC. Goldsboro, NC. Kinston, NC. Statesville, NC. Bismarck, ND. Bismarck, ND. Bismarck, ND. Akron, OH. Barberton, OH. Beachwood, OH. Cleveland, OH. Cleveland, OH. Columbus, OH. Independence, OH. Mayfield Heights, OH. Parma, OH. Sandusky, OH. Strongsville, OH. Wooster, OH. Clackamas, OR. Milwaukie, OR. Newberg, OR. Oregon City, OR. Portland, OR. Portland, OR. Portland, OR. Abington, PA. Danville, PA. Hazleton, PA. Philadelphia, PA. Philadelphia, PA. Pittsburgh, PA. State College, PA. Wilkes-Barre, PA. Charleston, SC. Danville, VA. Vancouver, WA. Vancouver, WA. La Crosse, WI.
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Bile Duct Neoplasms, Anxiety Disorders
Last Updated: July 22, 2021
Status: Completed
Locations: La Jolla, CA. Honolulu, HI. Chicago, IL. Evanston, IL. Glenview, IL. Highland Park, IL. Iowa City, IA. Boston, MA. Grand Rapids, MI. Minneapolis, MN. Rochester, MN. Saint Louis Park, MN. Saint Paul, MN. Lebanon, NH. New Hyde Park, NY. New York, NY. Durham, NC. Grand Forks, ND. Oklahoma City, OK. Richmond, VA. La Crosse, WI. Marshfield, WI. Milwaukee, WI.
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.
Conditions: Mesothelioma
Last Updated: July 13, 2021
Status: Completed
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
Conditions: Mesothelioma
Last Updated: June 30, 2021
Status: Completed
Locations: Scottsdale, AZ. Tucson, AZ. Duarte, CA. Chicago, IL. Detroit, MI. Las Vegas, NV. Albuquerque, NM. New York, NY. Cleveland, OH. Hershey, PA. San Antonio, TX. Salt Lake City, UT.
Alvopem® (Pemetrexed) Safety Assessment
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Last Updated: April 10, 2021
Status: Completed
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Conditions: Neoplasms
Last Updated: April 6, 2021
Status: Completed
Locations: New York, NY. New York, NY. Durham, NC. Houston, TX. San Antonio, TX. Salt Lake City, UT. Milano, Michigan. Modena, Missouri.
Olaparib in People With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 16, 2021
Status: Completed
Locations: Bethesda, MD.
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 16, 2021
Status: Completed
Locations: Los Angeles, CA. Los Angeles, CA. San Francisco, CA. Boston, MA. Boston, MA. Rochester, MN. New York, NY.
Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 13, 2021
Status: Completed
Locations: Bethesda, MD.
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 6, 2021
Status: Completed
Locations: Bethesda, MD.
Diadem to Investigate the Activity and Safety of Durvalumab
Conditions: Mesothelioma
Last Updated: March 3, 2021
Status: Completed
Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
Conditions: Mesothelioma
Last Updated: February 9, 2021
Status: Completed
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 20, 2021
Status: Completed
Locations: Rozzano, Michigan.
Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: January 20, 2021
Status: Completed
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 19, 2021
Status: Completed
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: January 8, 2021
Status: Completed
Locations: Rochester, MN.
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Fever
Last Updated: January 7, 2021
Status: Completed
Locations: Bronx, NY.
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Carcinoma, Non-Small-Cell Lung
Last Updated: December 16, 2020
Status: Completed
Locations: Fayetteville, AR. Augusta, GA. Chicago, IL. Houston, TX.
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Conditions: Mesothelioma, Pleural Effusion, Malignant, Pleural Effusion
Last Updated: December 2, 2020
Status: Completed
Locations: Philadelphia, PA.
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Triple Negative Breast Neoplasms, Mesothelioma, Squamous Cell Carcinoma of Head and Neck, Microsatellite Instability
Last Updated: October 28, 2020
Status: Completed
Locations: Los Angeles, CA. Hackensack, NJ. Huntersville, NC. Nashville, TN.
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Conditions: Mesothelioma
Last Updated: October 28, 2020
Status: Completed
Locations: La Jolla, CA. Aurora, CO. Norwich, CT. Tampa, FL. Chicago, IL. Chicago, IL. New Orleans, LA. Bethesda, MD. Rochester, MN. Buffalo, NY. New York, NY. Durham, NC. Cleveland, OH. Dallas, TX. Houston, TX.
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)
Conditions: Mesothelioma
Last Updated: October 1, 2020
Status: Completed
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 30, 2020
Status: Completed
Locations: Dallas, TX.
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
Conditions: Mesothelioma
Last Updated: September 29, 2020
Status: Completed
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 28, 2020
Status: Completed
Locations: San Francisco, CA. Tampa, FL. Chicago, IL. Bethesda, MD. Philadelphia, PA.
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 23, 2020
Status: Completed
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma
Last Updated: September 20, 2020
Status: Completed
Locations: Boston, MA.
MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma.
Conditions: Mesothelioma, Pleural Effusion
Last Updated: September 15, 2020
Status: Completed
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Conditions: Neoplasms
Last Updated: August 25, 2020
Status: Completed
Locations: Birmingham, AL. Scottsdale, AZ. Los Angeles, CA. Miami, FL. Ann Arbor, MI. Detroit, MI. Hackensack, NJ. New Brunswick, NJ. New York, NY. Rochester, NY. Huntersville, NC. Portland, OR. Philadelphia, PA. Nashville, TN. Nashville, TN.
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Conditions: Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms
Last Updated: July 30, 2020
Status: Completed
Locations: Los Angeles, CA.
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Neoplasms, Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pancreatic Neoplasms
Last Updated: July 6, 2020
Status: Completed
Locations: Pittsburgh, PA.
Clinical and Histopathologic Characteristics of BAP1 Mutations
Conditions: Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma, Uveal Neoplasms
Last Updated: June 30, 2020
Status: Completed
Locations: Harrison, NY. New York, NY.
A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas
Conditions: Lymphoma
Last Updated: June 24, 2020
Status: Completed
Locations: San Francisco, CA. Denver, CO. Sarasota, FL. Chicago, IL. Detroit, MI. New York, NY. New York, NY. Huntersville, NC. Pittsburgh, PA. Nashville, TN. Houston, TX.
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Conditions: Mesothelioma
Last Updated: May 22, 2020
Status: Completed
Locations: Bethesda, MD.
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Conditions: Mesothelioma, Pleural Effusion, Malignant, Pleural Effusion
Last Updated: May 12, 2020
Status: Completed
Locations: Philadelphia, PA.
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 6, 2020
Status: Completed
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 31, 2020
Status: Completed
Locations: Philadelphia, PA.
Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.
Conditions: Carcinoma
Last Updated: March 21, 2020
Status: Completed
Gene Therapy for Pleural Malignancies
Conditions: Mesothelioma, Pleural Effusion
Last Updated: March 16, 2020
Status: Completed
Locations: Philadelphia, PA.
Combination Gene Transfer and Chemotherapy
Conditions: Mesothelioma
Last Updated: March 13, 2020
Status: Completed
Locations: Philadelphia, PA.
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Conditions: Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms
Last Updated: February 27, 2020
Status: Completed
Locations: Philadelphia, PA.
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: February 19, 2020
Status: Completed
Locations: Tucson, AZ. Los Angeles, CA. Marysville, CA. Orange, CA. Pleasanton, CA. Sacramento, CA. Alamosa, CO. Aurora, CO. Edwards, CO. Glenwood Springs, CO. Montrose, CO. Hartford, CT. Gainesville, GA. Decatur, IL. Naperville, IL. Springfield, IL. Beech Grove, IN. Richmond, IN. Chanute, KS. Dodge City, KS. El Dorado, KS. Fort Scott, KS. Independence, KS. Kingman, KS. Lawrence, KS. Liberal, KS. Newton, KS. Parsons, KS. Pratt, KS. Salina, KS. Salina, KS. Wellington, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Wichita, KS. Winfield, KS. Ann Arbor, MI. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Detroit, MI. Flint, MI. Flint, MI. Grosse Pointe Woods, MI. Jackson, MI. Lansing, MI. Livonia, MI. Pontiac, MI. Port Huron, MI. Saginaw, MI. Warren, MI. Billings, MT. Billings, MT. Billings, MT. Billings, MT. Bozeman, MT. Butte, MT. Great Falls, MT. Great Falls, MT. Havre, MT. Helena, MT. Kalispell, MT. Kalispell, MT. Kalispell, MT. Missoula, MT. Missoula, MT. Albuquerque, NM. Charlotte, NC. Goldsboro, NC. Statesville, NC. Bellefontaine, OH. Chillicothe, OH. Columbus, OH. Columbus, OH. Columbus, OH. Columbus, OH. Columbus, OH. Dayton, OH. Dayton, OH. Dayton, OH. Dayton, OH. Dayton, OH. Delaware, OH. Findlay, OH. Franklin, OH. Greenville, OH. Kettering, OH. Lancaster, OH. Marietta, OH. Mount Vernon, OH. Newark, OH. Springfield, OH. Troy, OH. Westerville, OH. Wilmington, OH. Xenia, OH. Zanesville, OH. Clackamas, OR. Milwaukie, OR. Newberg, OR. Oregon City, OR. Portland, OR. Portland, OR. Portland, OR. Kingsport, TN. Knoxville, TN. Houston, TX. Danville, VA. Norton, VA. Bellingham, WA. Bremerton, WA. Kennewick, WA. Mount Vernon, WA. Poulsbo, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Spokane, WA. Spokane, WA. Vancouver, WA. Vancouver, WA. Wenatchee, WA. Casper, WY. Sheridan, WY.
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Conditions: Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms, Mesothelioma, Gastrointestinal Stromal Tumors
Last Updated: February 13, 2020
Status: Completed
Locations: San Francisco, CA. Stanford, CA. Sarasota, FL. Atlanta, GA. Bethesda, MD. Boston, MA. Boston, MA. Boston, MA. New York, NY. New York, NY. Philadelphia, PA. Nashville, TN. Houston, TX.
ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Conditions: Mesothelioma
Last Updated: January 22, 2020
Status: Completed
Locations: Alessandria, Alabama. Rozzano, Michigan.
Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 8, 2019
Status: Completed
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Conditions: Mesothelioma
Last Updated: November 6, 2019
Status: Completed
Locations: Chicago, IL. Bethesda, MD. Detroit, MI. Charleston, SC.
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Conditions: Mesothelioma
Last Updated: October 15, 2019
Status: Completed
Locations: New York, NY.
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Neoplasms, Mesothelioma
Last Updated: October 3, 2019
Status: Completed
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Carcinoma, Non-Small-Cell Lung
Last Updated: September 27, 2019
Status: Completed
Locations: Bethesda, MD.
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
Conditions: Mesothelioma
Last Updated: September 19, 2019
Status: Completed
Locations: Ventura, CA.
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Conditions: Mesothelioma
Last Updated: August 28, 2019
Status: Completed
Locations: Corona, CA. Duarte, CA. Tampa, FL. Baltimore, MD. New York, NY. Philadelphia, PA. Dallas, TX.
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Pleural Effusion
Last Updated: August 5, 2019
Status: Completed
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
Conditions: Neoplasms
Last Updated: July 16, 2019
Status: Completed
Locations: Birmingham, AL. Anchorage, AK. Phoenix, AZ. Little Rock, AR. Pismo Beach, CA. Sacramento, CA. Denver, CO. Danbury, CT. New Haven, CT. Norwalk, CT. Stamford, CT. Orlando, FL. Marietta, GA. Rome, GA. Honolulu, HI. Chicago, IL. Indianapolis, IN. South Bend, IN. Iowa City, IA. Scarborough, ME. Baltimore, MD. Ann Arbor, MI. Grand Rapids, MI. Kansas City, MO. Kansas City, MO. Las Vegas, NV. Camden, NJ. New Brunswick, NJ. Albuquerque, NM. Albuquerque, NM. Johnson City, NY. Chapel Hill, NC. Hickory, NC. Winston-Salem, NC. Cincinnati, OH. Cleveland, OH. Columbus, OH. Portland, OR. Salem, OR. Philadelphia, PA. Providence, RI. Greenville, SC. Sioux Falls, SD. Chattanooga, TN. Memphis, TN. Nashville, TN. Corpus Christi, TX. Houston, TX. Houston, TX. San Antonio, TX. Murray, UT. Salt Lake City, UT. Winchester, VA. Kennewick, WA. Olympia, WA. Tacoma, WA. Tacoma, WA. Walla Walla, WA. Wenatchee, WA. Milwaukee, WI. Milwaukee, WI.
A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors
Conditions:
Last Updated: July 10, 2019
Status: Completed
Malignant Mesothelioma - Can we Improve Quality of Life
Conditions: Mesothelioma
Last Updated: June 12, 2019
Status: Completed
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Conditions: Mesothelioma, Pancreatic Neoplasms, Adenocarcinoma of Lung
Last Updated: June 5, 2019
Status: Completed
Locations: Bethesda, MD.
E-MOSAIC Electronic Tool to Monitor Symptoms
Conditions:
Last Updated: May 14, 2019
Status: Completed
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: May 13, 2019
Status: Completed
CART-meso in Mesothelin Expressing Cancers
Conditions: Mesothelioma, Carcinoma, Ovarian Epithelial
Last Updated: February 22, 2019
Status: Completed
Locations: Philadelphia, PA.
Chest Wall Motion Analysis in Disease
Conditions: Empyema, Empyema, Pleural, Mesothelioma, Lung Neoplasms, Funnel Chest, Pectus Carinatum, Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive
Last Updated: February 21, 2019
Status: Completed
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM
Conditions: Mesothelioma
Last Updated: January 14, 2019
Status: Completed
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 14, 2019
Status: Completed
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
Conditions: Carcinoma, Carcinoma, Renal Cell, Mesothelioma, Intestinal Neoplasms, Gastrointestinal Neoplasms
Last Updated: January 10, 2019
Status: Completed
18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: Breast Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Renal Cell, Lymphoma, B-Cell
Last Updated: December 11, 2018
Status: Completed
Locations: Stanford, CA.
Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma
Conditions: Neoplasms, Mesothelioma, Lung Neoplasms
Last Updated: December 11, 2018
Status: Completed
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 5, 2018
Status: Completed
WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Conditions: Mesothelioma
Last Updated: November 1, 2018
Status: Completed
Locations: New York, NY.
Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)
Conditions: Mesothelioma
Last Updated: September 21, 2018
Status: Completed
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: September 17, 2018
Status: Completed
Locations: Chicago, IL.
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma
Conditions: Neoplasms, Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Thyroid Neoplasms, Pneumothorax, Thyroid Diseases
Last Updated: July 20, 2018
Status: Completed
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 11, 2018
Status: Completed
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Conditions: Colonic Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Carcinoma, Ovarian Epithelial, Germinoma, Ovarian Neoplasms, Lung Neoplasms, Pseudomyxoma Peritonei
Last Updated: July 2, 2018
Status: Completed
Locations: Winston-Salem, NC.
Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: June 12, 2018
Status: Completed
Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies
Conditions: Neoplasms
Last Updated: June 1, 2018
Status: Completed
A Study in Non Small Cell Lung Cancer
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Last Updated: May 16, 2018
Status: Completed
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: May 4, 2018
Status: Completed
Locations: Duarte, CA.
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Mesothelioma
Last Updated: March 13, 2018
Status: Completed
Locations: Bethesda, MD.
Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: December 30, 2017
Status: Completed
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: December 27, 2017
Status: Completed
Locations: San Antonio, TX.
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: November 27, 2017
Status: Completed
Locations: Minneapolis, MN.
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Conditions: Mesothelioma
Last Updated: November 3, 2017
Status: Completed
Locations: Baltimore, MD. Rochester, MN. New York, NY. New York, NY. Winston-Salem, NC. Philadelphia, PA.
Autologous Redirected RNA Meso-CIR T Cells
Conditions: Mesothelioma
Last Updated: September 16, 2017
Status: Completed
Locations: Philadelphia, PA.
Nivolumab in Patients With Recurrent Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 13, 2017
Status: Completed
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
Conditions: Mesothelioma
Last Updated: July 17, 2017
Status: Completed
Locations: Houston, TX.
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Conditions: Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms
Last Updated: July 6, 2017
Status: Completed
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Conditions: Mesothelioma
Last Updated: June 8, 2017
Status: Completed
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Conditions: Mesothelioma
Last Updated: April 24, 2017
Status: Completed
Locations: Birmingham, AL.
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Last Updated: April 5, 2017
Status: Completed
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: February 27, 2017
Status: Completed
Thrombin Generation and Platelet Activation in CRS/HIPEC
Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei
Last Updated: January 24, 2017
Status: Completed
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 19, 2017
Status: Completed
Locations: Boston, MA.
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: December 5, 2016
Status: Completed
Locations: Mobile, AL. Scottsdale, AZ. Jacksonville, FL. Peoria, IL. Urbana, IL. Cedar Rapids, IA. Des Moines, IA. Sioux City, IA. Wichita, KS. New Orleans, LA. Ann Arbor, MI. Duluth, MN. Rochester, MN. Saint Cloud, MN. Saint Louis Park, MN. Omaha, NE. Bismarck, ND. Fargo, ND. Toledo, OH. Danville, PA. Spartanburg, SC. Rapid City, SD. Sioux Falls, SD. Green Bay, WI.
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Conditions: Rare Diseases
Last Updated: November 16, 2016
Status: Completed
Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Rhabdomyosarcoma, Germinoma, Leiomyosarcoma, Vulvar Neoplasms, Vaginal Neoplasms, Cystadenocarcinoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Carcinoma, Adenosquamous, Cystadenocarcinoma, Serous, Brenner Tumor, Sarcoma, Endometrial Stromal, Rhabdomyosarcoma, Embryonal
Last Updated: October 26, 2016
Status: Completed
Locations: Fayetteville, AR. Fayetteville, AR. Little Rock, AR. Burbank, CA. Long Beach, CA. Los Angeles, CA. Orange, CA. Palo Alto, CA. Sacramento, CA. San Francisco, CA. Sylmar, CA. Aurora, CO. Aurora, CO. Danbury, CT. Hartford, CT. New Britain, CT. New Haven, CT. Fort Lauderdale, FL. Fort Myers, FL. Jupiter, FL. Miami, FL. Atlanta, GA. Augusta, GA. Gainesville, GA. Savannah, GA. Chicago, IL. Chicago, IL. Chicago, IL. Oak Lawn, IL. Springfield, IL. Indianapolis, IN. Indianapolis, IN. South Bend, IN. Clive, IA. Clive, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Des Moines, IA. Iowa City, IA. West Des Moines, IA. West Des Moines, IA. Ashland, KY. Edgewood, KY. Lexington, KY. Louisville, KY. Baton Rouge, LA. New Orleans, LA. Shreveport, LA. Portland, ME. Baltimore, MD. Baltimore, MD. Bethesda, MD. Springfield, MA. Worcester, MA. Worcester, MA. Ann Arbor, MI. Detroit, MI. Flint, MI. Grand Rapids, MI. Minneapolis, MN. Jackson, MS. Jackson, MS. Kessler AFB, MS. Columbia, MO. Saint Louis, MO. Saint Louis, MO. Springfield, MO. Springfield, MO. Springfield, MO. Omaha, NE. Las Vegas, NV. Las Vegas, NV. Lebanon, NH. Camden, NJ. Hackensack, NJ. Hackensack, NJ. Newark, NJ. Albuquerque, NM. Buffalo, NY. Mineola, NY. New York, NY. New York, NY. Stony Brook, NY. Chapel Hill, NC. Charlotte, NC. Charlotte, NC. Greenville, NC. Greenville, NC. Greenville, NC. Pinehurst, NC. Winston-Salem, NC. Akron, OH. Cincinnati, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Columbus, OH. Mentor, OH. Oklahoma City, OK. Tulsa, OK. Tulsa, OK. Portland, OR. Portland, OR. Abington, PA. Allentown, PA. Bethlehem, PA. Danville, PA. Philadelphia, PA. Philadelphia, PA. Pittsburgh, PA. Pittsburgh, PA. State College, PA. Wilkes-Barre, PA. Providence, RI. Charleston, SC. Greenville, SC. Spartanburg, SC. Rapid City, SD. Sioux Falls, SD. Sioux Falls, SD. Sioux Falls, SD. Chattanooga, TN. Johnson City, TN. Knoxville, TN. Memphis, TN. Nashville, TN. Nashville, TN. Amarillo, TX. Austin, TX. Dallas, TX. Dallas, TX. Dallas, TX. Dallas, TX. Fort Sam Houston, TX. Galveston, TX. Houston, TX. Lackland AFB, TX. Lubbock, TX. Lubbock, TX. Temple, TX. Hampton, VA. Roanoke, VA. Auburn, WA. Centralia, WA. Federal Way, WA. Lakewood, WA. Olympia, WA. Olympia, WA. Puyallup, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Seattle, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Tacoma, WA. Chippewa Falls, WI. Eau Claire, WI. Eau Claire, WI. Ladysmith, WI. Madison, WI. Marshfield, WI. Marshfield, WI. Milwaukee, WI. Milwaukee, WI. Milwaukee, WI. Minocqua, WI. Rhinelander, WI. Rice Lake, WI. Stevens Point, WI. Stevens Point, WI. Wausau, WI. West Allis, WI. Weston, WI. Weston, WI. Wisconsin Rapids, WI.
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Conditions: Mesothelioma
Last Updated: September 28, 2016
Status: Completed
Locations: Bethesda, MD.
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study
Conditions: Mesothelioma
Last Updated: September 1, 2016
Status: Completed
Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Conditions: Mesothelioma
Last Updated: July 25, 2016
Status: Completed
Capecitabine in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 12, 2016
Status: Completed
Locations: Birmingham, AL. La Jolla, CA. San Francisco, CA. San Francisco, CA. Wilmington, DE. Miami Beach, FL. Chicago, IL. Chicago, IL. Chicago, IL. Bettendorf, IA. Iowa City, IA. Togus, ME. Baltimore, MD. Boston, MA. Worcester, MA. Minneapolis, MN. Minneapolis, MN. Columbia, MO. Columbia, MO. Saint Louis, MO. Omaha, NE. Las Vegas, NV. Lebanon, NH. Buffalo, NY. Buffalo, NY. Manhasset, NY. Manhasset, NY. New York, NY. New York, NY. New York, NY. Syracuse, NY. Syracuse, NY. Syracuse, NY. Chapel Hill, NC. Durham, NC. Durham, NC. Winston-Salem, NC. Winston-Salem, NC. Columbus, OH. Providence, RI. Charleston, SC. Memphis, TN. Memphis, TN. Bennington, VT. Burlington, VT. White River Junction, VT. Richmond, VA. Richmond, VA.
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 11, 2016
Status: Completed
Locations: La Jolla, CA. San Francisco, CA. Lewes, DE. Newark, DE. Orlando, FL. Savannah, GA. Chicago, IL. Elkhart, IN. Fort Wayne, IN. Kokomo, IN. La Porte, IN. South Bend, IN. South Bend, IN. South Bend, IN. South Bend, IN. Baltimore, MD. Elkton MD, MD. Boston, MA. Boston, MA. St. Joseph, MI. Minneapolis, MN. Saint Louis, MO. Saint Louis, MO. Omaha, NE. Voorhees, NJ. Syracuse, NY. Durham, NC. Goldsboro, NC. Kinston, NC. Statesville, NC. Winston-Salem, NC. Columbus, OH. Greenville, SC. Berlin, VT. Burlington, VT. Danville, VA.
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 30, 2016
Status: Completed
Locations: Anniston, AL. Birmingham, AL. La Jolla, CA. Los Angeles, CA. San Diego, CA. San Diego, CA. San Francisco, CA. San Francisco, CA. Newark, DE. Fort Lauderdale, FL. Hollywood, FL. Miami Beach, FL. Orlando, FL. Chicago, IL. Chicago, IL. Chicago, IL. Chicago, IL. Peoria, IL. River Forest, IL. Fort Wayne, IN. South Bend, IN. Iowa City, IA. Louisville, KY. Baltimore, MD. Boston, MA. Worcester, MA. Saint Joseph, MI. Minneapolis, MN. Minneapolis, MN. Columbia, MO. Columbia, MO. Kansas City, MO. Saint Louis, MO. Saint Louis, MO. Omaha, NE. Las Vegas, NV. Las Vegas, NV. Hooksett, NH. Lebanon, NH. Camden, NJ. Buffalo, NY. Buffalo, NY. East Syracuse, NY. Elmhurst, NY. Jamaica, NY. Manhasset, NY. Manhasset, NY. New York, NY. New York, NY. New York, NY. Syracuse, NY. Syracuse, NY. Asheville, NC. Chapel Hill, NC. Concord, NC. Durham, NC. Durham, NC. Fayetteville, NC. Goldsboro, NC. Kinston, NC. Pinehurst, NC. Wilmington, NC. Winston-Salem, NC. Columbus, OH. Oklahoma City, OK. Pittsburgh, PA. Providence, RI. Memphis, TN. Memphis, TN. Dallas, TX. Dallas, TX. Burlington, VT. Charlottesville, VA. Norfolk, VA. Richmond, VA. Roanoke, VA. Huntington, WV.
Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)
Conditions: Mesothelioma
Last Updated: May 29, 2016
Status: Completed
Tomotherapy Treatment for Mesothelioma
Conditions: Mesothelioma
Last Updated: April 5, 2016
Status: Completed
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Conditions: Leukemia, Lung Neoplasms, Preleukemia, Mesothelioma, Myelodysplastic Syndromes, Syndrome
Last Updated: February 2, 2016
Status: Completed
Locations: New York, NY.
B-Receptor Signaling in Cardiomyopathy
Conditions: Carcinoma, Multiple Myeloma, Sarcoma, Preleukemia, Urinary Bladder Neoplasms, Mesothelioma, Neuroendocrine Tumors, Cholangiocarcinoma, Gastrointestinal Stromal Tumors, Hodgkin Disease, Anus Neoplasms, Carcinoma, Transitional Cell, Lymphoma, Non-Hodgkin, Testicular Neoplasms, Bone Neoplasms, Gallbladder Neoplasms, Eye Neoplasms, Endocrine Gland Neoplasms, Thymus Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Stomach Neoplasms, Cardiomyopathies, Myelodysplastic Syndromes, Myeloproliferative Disorders, Amyloidosis
Last Updated: November 16, 2015
Status: Completed
Locations: Stanford, CA.
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: November 16, 2015
Status: Completed
Locations: Houston, TX.
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 13, 2015
Status: Completed
Locations: Birmingham, AL. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Aurora, CO. Newark, DE. Atlanta, GA. Chicago, IL. Baltimore, MD. Bethesda, MD. New York, NY. Morgantown, WV.
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Conditions: Neoplasms, Mesothelioma, Colonic Neoplasms, Peritoneal Neoplasms, Abdominal Neoplasms
Last Updated: October 19, 2015
Status: Completed
Locations: Bethesda, MD.
Intrapleural Gene Transfer for Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 21, 2015
Status: Completed
Locations: Philadelphia, PA.
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma
Last Updated: July 7, 2015
Status: Completed
Locations: New Haven, CT. New York, NY. New York, NY. Houston, TX.
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Conditions: Neoplasms
Last Updated: July 7, 2015
Status: Completed
Locations: Scottsdale, AZ. Omaha, NE. Portsmouth, NH.
Isolated Thoracic Perfusion (ITP-F) for MPM
Conditions: Mesothelioma
Last Updated: June 9, 2015
Status: Completed
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms
Last Updated: April 29, 2015
Status: Completed
Locations: Bethesda, MD.
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms
Last Updated: April 29, 2015
Status: Completed
Locations: Bethesda, MD. Winston-Salem, NC.
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
Conditions: Lung Neoplasms, Esophageal Neoplasms, Mesothelioma
Last Updated: April 28, 2015
Status: Completed
Locations: Bethesda, MD. Bethesda, MD.
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Conditions: Mesothelioma
Last Updated: April 21, 2015
Status: Completed
Locations: Boston, MA. New York, NY. Philadelphia, PA.
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: February 11, 2015
Status: Completed
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: January 28, 2015
Status: Completed
Locations: Rochester, MN.
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: December 30, 2014
Status: Completed
Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients
Conditions: Mesothelioma
Last Updated: December 1, 2014
Status: Completed
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 25, 2014
Status: Completed
Locations: Chicago, IL.
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Conditions: Neoplasms, Melanoma, Small Cell Lung Carcinoma, Colorectal Neoplasms, Ovarian Neoplasms, Liposarcoma
Last Updated: July 23, 2014
Status: Completed
Locations: New York, NY.
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Ovarian Neoplasms, Mesothelioma
Last Updated: July 16, 2014
Status: Completed
Locations: Baltimore, MD. Bethesda, MD. Philadelphia, PA.
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: May 5, 2014
Status: Completed
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate
Conditions: Mesothelioma
Last Updated: March 26, 2014
Status: Completed
Locations: Boston, MA. Boston, MA.
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 26, 2014
Status: Completed
Locations: Boston, MA. Boston, MA.
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
Conditions: Mesothelioma
Last Updated: March 4, 2014
Status: Completed
Locations: Detroit, MI.
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: February 26, 2014
Status: Completed
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: February 10, 2014
Status: Completed
Locations: Chicago, IL.
Rapamycin With Grapefruit Juice for Advanced Malignancies
Conditions: Neoplasm Metastasis
Last Updated: January 16, 2014
Status: Completed
Locations: Chicago, IL.
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Conditions: Cancer Pain
Last Updated: January 14, 2014
Status: Completed
Locations: Chandler, AZ.
Serum Biomarkers in Diagnosis of Mesothelioma
Conditions: Mesothelioma
Last Updated: January 6, 2014
Status: Completed
Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms, Postoperative Complications
Last Updated: December 18, 2013
Status: Completed
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: August 6, 2013
Status: Completed
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Carcinoma, Sarcoma, Liver Neoplasms, Mesothelioma, Nervous System Neoplasms, Central Nervous System Neoplasms, Pheochromocytoma, Adrenocortical Carcinoma
Last Updated: July 9, 2013
Status: Completed
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Conditions: Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Mesothelioma, Kidney Neoplasms
Last Updated: July 9, 2013
Status: Completed
Locations: Los Angeles, CA.
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 27, 2013
Status: Completed
Alanosine in Treating Patients With Cancer
Conditions: Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Mesothelioma
Last Updated: June 25, 2013
Status: Completed
Locations: Birmingham, AL. Tucson, AZ. La Verne, CA. Los Angeles, CA. Boca Raton, FL. Chicago, IL. Skokie, IL. New York, NY. New York, NY. Nashville, TN. Houston, TX. Houston, TX.
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 17, 2013
Status: Completed
Locations: New Brunswick, NJ. New York, NY. Cleveland, OH.
Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 4, 2013
Status: Completed
Locations: Chicago, IL. Boston, MA.
SU5416 in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: May 31, 2013
Status: Completed
Locations: Chicago, IL. Chicago, IL. Chicago, IL. Decatur, IL. Evanston, IL. Park Ridge, IL. Peoria, IL. Springfield, IL. Fort Wayne, IN. South Bend, IN.
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: April 16, 2013
Status: Completed
Locations: Marrero, LA. Philadelphia, PA. Newport News, VA.
Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)
Conditions: Mesothelioma, Fever
Last Updated: March 15, 2013
Status: Completed
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: January 23, 2013
Status: Completed
Locations: San Antonio, TX.
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Conditions: Carcinoma, Breast Neoplasms, Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Pancreatic Neoplasms, Glioblastoma, Rectal Neoplasms, Glioma, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Astrocytoma, Mesothelioma, Carcinoma, Ovarian Epithelial, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Carcinoma, Basal Cell, Carcinoma, Verrucous, Ependymoma, Gliosarcoma, Papilloma, Salivary Gland Neoplasms, Oligodendroglioma, Nasopharyngeal Carcinoma, Paranasal Sinus Neoplasms, Anus Neoplasms, Carcinoma, Adenoid Cystic, Neoplasms, Unknown Primary, Breast Neoplasms, Male, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory, Papilloma, Inverted, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Laryngeal Diseases, Granuloma
Last Updated: January 15, 2013
Status: Completed
Locations: Chicago, IL.
Gefitinib in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: January 15, 2013
Status: Completed
Locations: Chicago, IL.
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 30, 2012
Status: Completed
Locations: Norwich, CT. Lewes, DE. Newark, DE. Jacksonville, FL. Altanta, GA. Aurora, IL. Bloomington, IL. Canton, IL. Carthage, IL. Decatur, IL. Eureka, IL. Galesburg, IL. Galesburg, IL. Havana, IL. Hopedale, IL. Joliet, IL. Kewanee, IL. Macomb, IL. Moline, IL. Normal, IL. Normal, IL. Ottawa, IL. Ottawa, IL. Pekin, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peoria, IL. Peru, IL. Princeton, IL. Spring Valley, IL. Springfield, IL. Urbana, IL. Urbana, IL. Elkhart, IN. Indianapolis, IN. Indianapolis, IN. Indianapolis, IN. Kokomo, IN. La Porte, IN. Michigan City, IN. South Bend, IN. South Bend, IN. South Bend, IN. Ames, IA. Cedar Rapids, IA. Sioux City, IA. Sioux City, IA. Sioux City, IA. Baltimore, MD. Elkton MD, MD. Ann Arbor, MI. Ann Arbor, MI. Dearborn, MI. Flint, MI. Flint, MI. Grosse Pointe Woods, MI. Jackson, MI. Kalamazoo, MI. Kalamazoo, MI. Kalamazoo, MI. Lansing, MI. Saginaw, MI. St. Joseph, MI. Warren, MI. Burnsville, MN. Coon Rapids, MN. Duluth, MN. Duluth, MN. Duluth, MN. Edina, MN. Fridley, MN. Hutchinson, MN. Lichfield, MN. Maplewood, MN. Maplewood, MN. Minneapolis, MN. Minneapolis, MN. Robbinsdale, MN. Rochester, MN. Saint Louis Park, MN. Shakopee, MN. St Paul, MN. St. Louis Park, MN. St. Paul, MN. St. Paul, MN. Waconia, MN. Woodbury, MN. Woodbury, MN. East Orange, NJ. Hackensack, NJ. Marlton, NJ. New Brunswick, NJ. Voorhees, NJ. Voorhees, NJ. Bismarck, ND. Bismarck, ND. Bismarck, ND. Bismarck, ND. Akron, OH. Canton, OH. Cleveland, OH. Lima, OH. Allentown, PA. Hershey, PA. Lewistown, PA. Philadelphia, PA. Philadelphia, PA. State College, PA. Sioux Falls, SD. Sioux Falls, SD. Sioux Falls, SD. La Crosse, WI. Madison, WI.
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: October 5, 2012
Status: Completed
Locations: Mobile, AL. Phoenix, AZ. Phoenix, AZ. Tucson, AZ. Tucson, AZ. Little Rock, AR. Little Rock, AR. Long Beach, CA. Los Angeles, CA. Los Angeles, CA. Los Angeles, CA. Martinez, CA. Oakland, CA. Sacramento, CA. San Francisco, CA. Santa Rosa, CA. Travis Air Force Base, CA. Denver, CO. Denver, CO. Atlanta, GA. Fort Gordon, GA. Honolulu, HI. Decatur, IL. Hines, IL. Maywood, IL. Kansas City, KS. Wichita, KS. Wichita, KS. Lexington, KY. Lexington, KY. New Orleans, LA. New Orleans, LA. New Orleans, LA. Shreveport, LA. Shreveport, LA. Boston, MA. Jamaica Plain, MA. Ann Arbor, MI. Ann Arbor, MI. Detroit, MI. Detroit, MI. Detroit, MI. Grand Rapids, MI. Southfield, MI. Biloxi, MS. Jackson, MS. Jackson, MS. Keesler AFB, MS. Kansas City, MO. Kansas City, MO. Saint Louis, MO. Saint Louis, MO. Springfield, MO. Billings, MT. Albuquerque, NM. Albuquerque, NM. Brooklyn, NY. New York, NY. Cincinnati, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Dayton, OH. Kettering, OH. Oklahoma City, OK. Oklahoma City, OK. Portland, OR. Portland, OR. Portland, OR. Greenville, SC. Spartanburg, SC. Fort Sam Houston, TX. Galveston, TX. Lubbock, TX. San Antonio, TX. San Antonio, TX. Temple, TX. Temple, TX. Salt Lake City, UT. Salt Lake City, UT. Seattle, WA. Seattle, WA. Seattle, WA. Tacoma, WA.
Interleukin-12 in Treating Patients With Cancer in the Abdomen
Conditions: Colorectal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Anus Neoplasms, Gallbladder Neoplasms
Last Updated: July 27, 2012
Status: Completed
Locations: Houston, TX.
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 17, 2012
Status: Completed
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: July 17, 2012
Status: Completed
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: July 17, 2012
Status: Completed
An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: June 5, 2012
Status: Completed
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Conditions: Mesothelioma
Last Updated: May 14, 2012
Status: Completed
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Conditions: Lung Neoplasms, Mesothelioma
Last Updated: March 14, 2012
Status: Completed
Locations: Bethesda, MD.
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma
Last Updated: March 14, 2012
Status: Completed
Locations: Bethesda, MD. Bethesda, MD. Bethesda, MD.
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Conditions: Mesothelioma
Last Updated: December 23, 2011
Status: Completed
Locations: Chicago, IL. Boston, MA. Boston, MA.
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
Conditions:
Last Updated: September 26, 2011
Status: Completed
Locations: Tampa, FL.
Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: August 31, 2011
Status: Completed
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
Conditions: Mesothelioma
Last Updated: May 14, 2011
Status: Completed
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Conditions:
Last Updated: April 23, 2011
Status: Completed
Locations: New York, NY.
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors
Conditions:
Last Updated: April 7, 2011
Status: Completed
Locations: Aurora, CO.
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 25, 2011
Status: Completed
Locations: New York, NY. Houston, TX.
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Conditions: Lung Neoplasms, Mesothelioma
Last Updated: March 3, 2011
Status: Completed
Locations: Buffalo, NY.
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: February 25, 2011
Status: Completed
Locations: Buffalo, NY.
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment
Conditions: Mesothelioma
Last Updated: November 17, 2010
Status: Completed
Dendritic Cell-based Immunotherapy in Mesothelioma
Conditions: Mesothelioma
Last Updated: November 15, 2010
Status: Completed
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
Conditions: Carcinoma, Sarcoma, Mesothelioma, Breast Neoplasms, Endometrial Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Esophageal Neoplasms, Testicular Neoplasms, Small Cell Lung Carcinoma, Carcinoma, Neuroendocrine
Last Updated: August 2, 2010
Status: Completed
Locations: Tuscon, AZ. Tampa, FL. Sparks, NV. Lebanon, NH.
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
Conditions: Lung Neoplasms, Mesothelioma
Last Updated: June 10, 2010
Status: Completed
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 17, 2009
Status: Completed
Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Conditions: Mesothelioma, Pleural Neoplasms
Last Updated: May 1, 2009
Status: Completed
Locations: San Francisco, CA. Chicago, IL. Baltimore, MD. Boston, MA. Detroit, MI. New York, NY. Houston, TX.
Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy
Conditions: Pleural Effusion, Pleural Diseases
Last Updated: July 22, 2008
Status: Completed
Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: November 5, 2007
Status: Completed
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 10, 2007
Status: Completed
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma
Conditions: Mesothelioma
Last Updated: January 24, 2007
Status: Completed
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: January 24, 2007
Status: Completed
Locations: Aurora, CO. Tampa, FL. Chicago, IL. Boston, MA. Detroit, MI. Albuquerque, NM. New York, NY. Cleveland, OH. Philadelphia, PA. Pittsburgh, PA.
